Conveners
Applications
- Thierry Stora (CERN)
-
Dr Joao Pedro Ramos (KU Leven and CERN)06/12/2018, 09:00Invited
The ISOLDE facility uses about 50-60% of all the CERN protons on its two targets to produce radioactive isotopes for physics research. Most of these protons go through the ISOLDE targets into the dumps, without any interaction, only having their energy slightly reduced. To "recycle" these protons, the MEDICIS facility (MEDical Isotopes Collected from ISOLDE) was created to fulfill the demand...
Go to contribution page -
Nicholas Philip Van Der Meulen (Paul Scherrer Institut (CH))06/12/2018, 09:30Invited
Terbium is a unique element, as it provides a quadruplet of radionuclides suited for diagnostics and therapy in nuclear medicine [1]. Much success has been gained from the PSI-ISOLDE collaboration, with the collection and purification of 149Tb (α-emitter, T1/2 = 4.1 h – for potential therapy), used for preclinical therapy studies [2] and PET imaging [3], and 152Tb (β+-emitter, T1/2 = 17.5 h –...
Go to contribution page -
Mrs Varvara Lagaki (CERN, University of Greifswald)06/12/2018, 10:00Submitted
Collinear laser spectroscopy (CLS) is a powerful tool to access nuclear ground state properties such as nuclear spins, electromagnetic moments and mean-square charge radii of short-lived radionuclides far from stability with high precision and accuracy [1,2]. Performing CLS with fast beams (>30 keV) provides an excellent spectral resolution approaching the natural linewidth [1]. However,...
Go to contribution page